Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Penile Neoplasms 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Metastatic Solid Tumors 1Melanoma 1Lung Neoplasms 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1Anus Neoplasms 1

Interventions

pembrolizumab 14Cisplatin 13Specimen Handling 11Magnetic Resonance Spectroscopy 7Brachytherapy 7Bevacizumab 7Radiotherapy 6atezolizumab 5Platinum 5Paclitaxel 5Nivolumab 5Human Papillomavirus DNA Tests 5Gemcitabine 5Colposcopy 5Carboplatin 5Blood Specimen Collection 5Radiation 4Fulvestrant 4lenvatinib 3Surveys and Questionnaires 3Radiation Dose Hypofractionation 3Drug Therapy 3Biopsy 31,2-diaminocyclohexaneplatinum II citrate 3zimberelimab 2tisotumab vedotin 2spartalizumab 2palbociclib 2camrelizumab 2X-Rays 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × bintrafusp alfa protein, human × 90 days × Clear all
NCT04708470 2026-04-06

A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
55 enrolled
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡